Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system

Molecular Cloning: A Laboratory Manual

Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,075

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue

Duve, C. D., Pressman, B. C., Gianetto, R., Wattiaux, R., & Appelmans, F. (1955) · Biochemical Journal · doi:10.1042/bj0600604 · Cited by 4,176

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028

Functions of Lysosomes

de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033

Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes

Cox, K. H., DeLeon, D. V., Angerer, L. M., & Angerer, R. C. (1984) · Developmental Biology · doi:10.1016/0012-1606(84)90162-3 · Cited by 1,610

The Biogenesis of Lysosomes

Kornfeld, S. A., & Mellman, I. (1989) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.05.110189.002411 · Cited by 1,593

Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients

Pitto, M., Raimondo, F., Zoia, C., Brighina, L., Ferrarese, C., & Masserini, M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.006 · Cited by 31

Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression

Magini, A., Polchi, A., Tozzi, A., Tancini, B., Tantucci, M., Urbanelli, L., Borsello, T., Calabresi, P., & Emiliani, C. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.11.001 · Cited by 31

Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer’s Disease

Hernándes‐Alejandro, M., Montaño, S., Harrington, C. R., Wischik, C. M., Salas‐Casas, A., Cortés‐Reynosa, P., Salazar, E. P., Cázares-Ápatiga, J., Apátiga-Pérez, R., Ontiveros‐Torres, M. Á., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200146 · Cited by 30

Age-dependent shift in the de novo proteome accompanies pathogenesis in an Alzheimer’s disease mouse model

Elder, M. K., Erdjument‐Bromage, H., Oliveira, M. M., Mamcarz, M., Neubert, T. A., & Klann, E. (2021) · Communications Biology · doi:10.1038/s42003-021-02324-6 · Cited by 33

Native PLGA nanoparticles regulate APP metabolism and protect neurons against β-amyloid toxicity: Potential significance in Alzheimer's disease pathology

Wu, Q., Karthivashan, G., Nakhaei‐Nejad, M., Anand, B. G., Giuliani, F., & Kar, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.148 · Cited by 30

Cerebrospinal fluid levels of ??-amyloid(42) in patients with Alzheimer??s disease are related to the exon 2 polymorphism of the cathepsin D gene

Papassotiropoulos, A., Lewis, H. D., Bagli, M., Jessen, F., Ptok, U., Schulte, A., Shearman, M. S., & Heun, R. (2002) · Neuroreport · doi:10.1097/00001756-200207190-00015 · Cited by 31

Cathepsin D plays a crucial role in the trimethyltin-induced hippocampal neurodegeneration process

Ceccariglia, S., D’Altocolle, A., Fà, A. D., Pizzolante, F., Caccia, E., Michetti, F., & Gangitano, C. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.024 · Cited by 30

The Cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease

Riemenschneider, M. J., Blennow, K., Wagenpfeil, S., Andreasen, N., Prince, J. A., Laws, S. M., Förstl, H., & Kurz, A. (2006) · Human Mutation · doi:10.1002/humu.20326 · Cited by 30

Tau Pathology Induces Intraneuronal Cholesterol Accumulation

Glöckner, F., & Ohm, T. G. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000103 · Cited by 30

Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer’s Disease

Liu, X., Baxley, S., Hebron, M. L., Turner, R. S., & Moussa, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115044 · Cited by 29

Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β‐amyloid‐toxicity

Wang, Y., Wu, Q., Anand, B. G., Karthivashan, G., Phukan, G., Yang, J., Thinakaran, G., Westaway, D. A., & Kar, S. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12647 · Cited by 29

Cln1gene disruption in mice reveals a common pathogenic link between two of the most lethal childhood neurodegenerative lysosomal storage disorders

Chandra, G., Bagh, M. B., Peng, S., Saha, A., Sarkar, C., Moralle, M., Zhang, Z., & Mukherjee, A. B. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv266 · Cited by 28

Lysosomal peptidases—intriguing roles in cancer progression and neurodegeneration

Kos, J., Mitrović, A., Nanut, M. P., & Pišlar, A. H. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13372 · Cited by 29

Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer’s disease patients

Corlier, F. W., Rivals, I., Lagarde, J., Hamelin, L., Corne, H., Dauphinot, L., Ando, K., Cossec, J., Fontaine, G., Dorothée, G., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.87 · Cited by 28

Targeted quantitative analysis of synaptic proteins in Alzheimer’s disease brain

Chang, R. Y. K., Etheridge, N., Dodd, P. R., & Nouwens, A. S. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.05.011 · Cited by 28

The lysosome system is severely impaired in a cellular model of neurodegeneration induced by HSV-1 and oxidative stress

Kristen, H., Sastre, I., Muñoz‐Galdeano, T., Recuero, M., Aldudo, J., & Bullido, M. J. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.025 · Cited by 30

The imbalanced redox status in senescent endothelial cells is due to dysregulated Thioredoxin-1 and NADPH oxidase 4

Goy, C., Czypiorski, P., Altschmied, J., Jakob, S., Rabanter, L. L., Brewer, A. C., Ale‐Agha, N., Dyballa‐Rukes, N., Shah, A. M., & Haendeler, J. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.03.005 · Cited by 28

CA-074Me, a cathepsin B inhibitor, decreases APP accumulation and protects primary rat cortical neurons treated with okadaic acid

Cho, K., Yoon, S. Y., Choi, J. E., Kang, H. J., Jang, H. Y., & Kim, D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.05.056 · Cited by 27

Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons

Koike, M. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)81020-2 · Cited by 27

Differences in expression patterns of cathepsin C /dipeptidyl peptidase I in normal, pathological and aged mouse central nervous system

Koike, M., Shibata, M., Ezaki, J., Peters, C., Säftig, P., Kominami, E., & Uchiyama, Y. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12096 · Cited by 28

Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease

Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1205488 · Cited by 27

Cortical cathepsin D activity and immunolocalization in Alzheimer disease, critical coronary artery disease, and aging

Haas, U., & Sparks, D. L. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815189 · Cited by 27

Pleiotropic Effects of Cathepsin D

Vashishta, A., Ohri, S. S., & Větvička, V. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009789839174 · Cited by 28

Hyperphosphorylation of RNA Polymerase II and Reduced Neuronal RNA Levels Precede Neurofibrillary Tangles in Alzheimer Disease

Husseman, J. W., Hallows, J. L., Bregman, D. B., Leverenz, J. B., Nochlin, D., Jin, L., & Vincent, I. J. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1219 · Cited by 25

UsingDrosophilaModels of Amyloid Toxicity to Study Autophagy in the Pathogenesis of Alzheimer’s Disease

O’Keefe, L. V., & Denton, D. (2018) · BioMed Research International · doi:10.1155/2018/5195416 · Cited by 25

The Degradation of Amyloid β as a Therapeutic Strategy in Alzheimer's Disease and Cerebrovascular Amyloidoses

Morelli, L., Llovera, R. E., Ibendahl, S., & Castaño, E. M. (2002) · Neurochemical Research · doi:10.1023/a:1021679817756 · Cited by 25

Exploring the putative role of kallikrein‐6, calpain‐1 and cathepsin‐D in the proteolytic degradation of α‐synuclein in multiple system atrophy

Kiely, A. P., Miners, J. S., Courtney, R. J., Strand, C., Love, S., & Holton, J. L. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12512 · Cited by 23

Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome

Botté, A., & Potier, M. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.002 · Cited by 22

Removal of the glycosylphosphatidylinositol anchor from PrPSc by cathepsin D does not reduce prion infectivity

Lewis, P. A., Properzi, G., Prodromidou, K., Clarke, A. R., Collinge, J., & Jackson, G. S. (2006) · Biochemical Journal · doi:10.1042/bj20051677 · Cited by 24

Expression Profile Analysis of Neurodegenerative Disease: Advances in Specificity and Resolution

Glanzer, J. G., Haydon, P. G., & Eberwine, J. H. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023603.17615.8c · Cited by 24

Non-replication of association between cathepsin D genotype and late onset Alzheimer disease

Menzer, G., Müller‐Thomsen, T., Meins, W., Alberici, A., Binetti, G. G., Höck, C., Nitsch, R. M., Stoppe, G., Reiss, J., & Finckh, U. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1204 · Cited by 24

A Cellular Stress Model for the Differential Expression of Glial Lysosomal Cathepsins in the Aging Nervous System

Chopra, V. S., Moozar, K., Mehindate, K., & Schipper, H. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6616 · Cited by 24

Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice

Mirnics, K., Norstrom, E. M., Garbett, K., Choi, S., Zhang, X., Ebert, P., & Sisodia, S. S. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-14 · Cited by 23

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry

Sjödin, S., Öhrfelt, A., Brinkmalm, G., Zetterberg, H., Blennow, K., & Brinkmalm, A. (2016) · Clinical Proteomics · doi:10.1186/s12014-016-9104-2 · Cited by 24

From bedside to cell biology: A century of history on lysosomal dysfunction

Coutinho, M. F., Matos, L., & Alves, S. (2014) · Gene · doi:10.1016/j.gene.2014.09.054 · Cited by 22

Presenilin 1: more than just γ-secretase

Raemaekers, T., Esselens, C. W., & Annaert, W. G. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330559 · Cited by 22

Single-cell mapping of focused ultrasound-transfected brain

Mathew, A. S., Gorick, C. M., & Price, R. J. (2021) · Gene Therapy · doi:10.1038/s41434-021-00226-0 · Cited by 22

From rare to common and back again: 60years of lysosomal dysfunction

Coutinho, M. F., & Alves, S. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.08.008 · Cited by 25

Lysosomal Dysfunction Produces Distinct Alterations in Synaptic α-Amino-3-Hydroxy-5-Methylisoxazolepropionic Acid and N-Methyl-D-Aspartate Receptor Currents in Hippocampus

Kanju, P. M., Parameshwaran, K., Vaithianathan, T., Sims‐Robinson, C., Huggins, K. W., Bendiske, J., Ryzhikov, S., Bahr, B. A., & Suppiramaniam, V. D. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181461ae7 · Cited by 21

TFEB-mediated Enhancement of the Autophagy-lysosomal Pathway Dually Modulates the Process of Amyloid β-Protein Generation in Neurons.

Yamamoto, F., Taniguchi, K., Mamada, N., Tamaoka, A., Kametani, F., Lakshmana, M., & Araki, W. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.01.010 · Cited by 18

Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Aβ in a mice model of early-stage Alzheimer’s disease

Aladeokin, A. C., Akiyama, T. H., Kimura, A., Kimura, Y., Jitsuki‐Takahashi, A., Nakamura, H., Makihara, H., Masukawa, D., Nakabayashi, J., Hirano, H., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104603 · Cited by 23

Activation of cathepsin D by glycosaminoglycans

Beckman, M., Freeman, C. G., Parish, C. R., & Small, D. H. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07444.x · Cited by 21

Gene Expression Profiling in Neurological Disorders: Toward a Systems-Level Understanding of the Brain

Baranzini, S. E. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:031 · Cited by 21

Interplay between lysosomal, mitochondrial and death receptor pathways during manganese-induced apoptosis in glial cells

Gorojod, R. M., Alaimo, A., Alcon, S. P., Saravia, F., & Kotler, M. L. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1936-7 · Cited by 21

Differential Role of Melatonin in Healthy Brain Aging: A Systematic Review and Meta-Analysis of the SAMP8 Model

Sumsuzzman, D. M., Khan, Z. A., Choi, J., & Hong, Y. (2021) · Aging · doi:10.18632/aging.202894 · Cited by 19

Biochemical Characterization of Protein Quality Control Mechanisms during Disease Progression in the C22 Mouse Model of CMT1A

Chittoor-Vinod, V. G., Sooyeon, L., Rangaraju, S., Nicks, J., Schmidt, J. T., Madorsky, I., Narvaez, D. C., & Notterpek, L. M. (2013) · ASN NEURO · doi:10.1042/an20130024 · Cited by 19

Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy

Puska, G., Lutz, M. I., Molnár, K., Regelsberger, G., Ricken, G., Pirker, W., László, L., & Kovács, G. G. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.019 · Cited by 20

Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse model.

Malthankar‐Phatak, G. H., Lin, Y., Giovannone, N., & Siman, R. G. (2012) · Europe PMC (PubMed Central) · Cited by 18

Lysosomal Dysregulation in the Murine App Model of Alzheimer’s Disease

Whyte, L. S., Hassiotis, S., Hattersley, K. J., Hemsley, K. M., Hopwood, J. J., Lau, A. A., & Sargeant, T. J. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.12.042 · Cited by 19

Utility of endoscopic ultrasound for the diagnosis and treatment of submucosal tumors of the upper gastrointestinal tract.

Săftoiu, A., Vilmann, P., & Ciurea, T. (2003) · PubMed · Cited by 18

Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing

Vitória, J. J. M., Trigo, D., & Silva, O. A. B. D. C. E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04090-4 · Cited by 19

Critical role of ROCK1 in AD pathogenesis via controlling lysosomal biogenesis and acidification

Song, C., Huang, W., Zhang, P., Shi, J., Yu, T. Y., Wang, J., Hu, Y., Zhao, L., Zhang, R., Wang, G., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00442-9 · Cited by 19

Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia

Lee, J. Y., Marian, O. C., & Don, A. S. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08644-4 · Cited by 18

Experimental approaches for altering the expression of Abeta‐degrading enzymes

Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 18

Lysosomal Modulatory Drugs for a Broad Strategy Against Protein Accumulation Disorders

Bahr, B. A. (2009) · Current Alzheimer Research · doi:10.2174/156720509789207903 · Cited by 17

Nonpeptidic Lysosomal Modulators Derived from Z-Phe-Ala-Diazomethylketone for Treating Protein Accumulation Diseases

Viswanathan, K., Hoover, D. J., Hwang, J., Wisniewski, M. L., Ikonne, U. S., Bahr, B. A., & Wright, D. L. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300197h · Cited by 17

Increased Expression of Cathepsin D in Retrosplenial Cortex of MK-801-Treated Rats

Hetman, M., Danysz, W., & Kaczmarek, L. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6603 · Cited by 17

Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B

Wu, Y., Mumford, P., Noy, S., Cleverley, K., Mrzyglod, A., Luo, D., van Dalen, F., Verdoes, M., Fisher, E. M. C., & Wiseman, F. K. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01632-8 · Cited by 16

Lysosomal Dysfunction Reduces Brain-Derived Neurotrophic Factor Expression

Bednarski, E., Lauterborn, J. C., Gall, C. M., & LYNCH, G. S. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6747 · Cited by 16

Comparison of the amyloid plaque proteome in Down syndrome, early‐onset Alzheimer's disease, and late‐onset Alzheimer's disease

Martá-Ariza, M., Leitner, D. F., Kanshin, E., Suazo, J., Giusti Pedrosa, A., Thierry, M., Lee, E. B., Devinsky, O., Drummond, E., Fortea, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02844-z · Cited by 15

The Transcription Factor EB Reduces the Intraneuronal Accumulation of the Beta-Secretase-Derived APP Fragment C99 in Cellular and Mouse Alzheimer’s Disease Models

Bécot, A., Pardossi‐Piquard, R., Bourgeois, A., Duplan, E., Xiao, Q., Diwan, A., Lee, J., Lauritzen, I., & Checler, F. (2020) · Cells · doi:10.3390/cells9051204 · Cited by 16

Estrés oxidativo, péptido β-amiloide y enfermedad de Alzheimer

Manzano‐León, N., & Mas‐Oliva, J. (2006) · Gaceta Médica de México · Cited by 16

Protein Truncation as a Common Denominator of Human Neurodegenerative Foldopathies

Jadhav, S., Žilka, N., & Novák, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8440-8 · Cited by 15

Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP / PS 1 transgenic mice

Cheng, S., Wani, W. Y., Hottman, D. A., Jeong, A., Cao, D., LeBlanc, K. J., Säftig, P., Zhang, J., & Li, L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14048 · Cited by 15

Expression and characterization of human β-secretase candidates metalloendopeptidase MP78 and cathepsin D in βAPP-overexpressing cells

Thompson, A., Grueninger‐Leitch, F., Huber, G., & Malherbe, P. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00091-0 · Cited by 15

The Cathepsin D (224C/T) Polymorphism Confers an Increased Risk to Develop Alzheimer's Disease in Men

Albayrak, Ö., Tirniceriu, A., Riemenschneider, M. J., Kurz, A., Scherag, A., & Egensperger, R. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp209 · Cited by 15

Interconnections of insulin/IGF‐1 signaling and autophagy abnormalities in Alzheimer's disease

Liao, W., Xuan, J., Ryu, W., Bormann, M. K., Lee, Y., Dion, H., Evangelista, E., Li, R., Trambaiolli, L. R., Liu, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70099 · Cited by 14

Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations

Davis, S. E., Cook, A. K., Hall, J. A., Voskobiynyk, Y., Carullo, N. V. N., Boyle, N. R., Hakim, A. R., Anderson, K. M., Hobdy, K. P., Pugh, D. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01571-4 · Cited by 12

Human fibroblasts from sporadic Alzheimer's disease (AD) patients show mitochondrial alterations and lysosome dysfunction

Li, Y., Li, Z., Grillo, E., Desler, C., Navarro, C., Bohr, V. A., Berliocchi, L., & Rasmussen, L. J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.07.013 · Cited by 14

How close is autophagy-targeting therapy for Alzheimer's disease to clinical use? A summary of autophagy modulators in clinical studies

Fernandes, S. M., Mayer, J., Nilsson, P., & Shimozawa, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1520949 · Cited by 17

Expression profiling of precuneus layer III cathepsin D‐immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability

He, B., Perez, S. E., Lee, S. H., Ginsberg, S. D., Malek‐Ahmadi, M. H., & Mufson, E. J. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.24929 · Cited by 14

Flexible and Accurate Substrate Processing with Distinct Presenilin/γ-Secretases in Human Cortical Neurons

Watanabe, H., Imaizumi, K., Cai, T., Zhou, Z., Tomita, T., & Okano, H. (2021) · eNeuro · doi:10.1523/eneuro.0500-20.2021 · Cited by 15

Endo-Lysosomal and Autophagy Pathway and Ubiquitin-Proteasome System in Mood Disorders: A Review Article

Santos, P. M., Campos, G. P., & Nascimento, C. F. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s376380 · Cited by 15

Amniotic tissue in complete hydatidiform moles can be androgenetic

Weaver, D. T., Fisher, R. A., Newlands, E. S., & Paradinas, F. J. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200005)191:1 · Cited by 29

Analysis of Message Expression in Single Neurons of Alzheimer’s Disease Brain

Callahan, L. M., Chow, N., Cheetham, J., Cox, C., & Coleman, P. D. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00044-x · Cited by 14

Programmed Cell Death and Apoptosis in Fungi

Ramsdale, M. (2006) · Springer eBooks · doi:10.1007/3-540-30809-1_7 · Cited by 14

Truncated tau interferes with the autophagy and endolysosomal pathway and results in lipid accumulation

Pollack, S. J., Dakkak, D., Guo, T., Chennell, G., Gomez-Suaga, P., Noble, W., Jimenez-Sanchez, M., & Hanger, D. P. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05337-6 · Cited by 14

Cathepsins: Getting in Shape for Lysosomal Proteolysis

Erickson, A. H., Isidoro, C., Mach, L., & Mort, J. S. (2013) · Springer eBooks · doi:10.1007/978-3-7091-0885-7_4 · Cited by 14

Alteration of Protease Levels in Different Brain Areas of Suicide Victims

Banay‐Schwartz, M., DeGuzman, T., Faludi, G., Lajtha, Á., & Palkovits, M. (1998) · Neurochemical Research · doi:10.1023/a:1021028304481 · Cited by 13

Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer’s Disease

Snir, J. A., Suchý, M., Lawrence, K. S., Hudson, R. H. E., Pasternak, S., & Bartha, R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150123 · Cited by 13

Disease‐specific neuropathological alterations of the locus coeruleus in Alzheimer's disease, Down syndrome, and Parkinson's disease

Fructuoso, M., Vermeiren, Y., Boluda, S., Stimmer, L., Crans, R. A. J., Xicota, L., Eisel, U., Ortí-Casañ, N., Bun, P., Duyckaerts, C. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70262 · Cited by 14

Untangling the role of tau in Alzheimer’s disease: A unifying hypothesis

Bhatia, N. S., & Hall, G. F. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0114-5 · Cited by 11

A Novel Dual Fluorochrome Near-Infrared Imaging Probe for Potential Alzheimer’s Enzyme Biomarkers-BACE1 and Cathepsin D

Tam, J. M., Josephson, L., Pilozzi, A. R., & Huang, X. (2020) · Molecules · doi:10.3390/molecules25020274 · Cited by 11

Protease Inhibitors and their Involvement in Neurological Disorders

Tizón, B., & Levy, E. (2007) · Springer eBooks · doi:10.1007/978-0-387-30379-6_20 · Cited by 11

The Link Between Lysosomal Storage Disorders and More Common Diseases

Beck, M. (2016) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1177/2326409816682767 · Cited by 11

An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer’s Disease Mouse Model

Snir, J. A., Suchý, M., Bindseil, G. A., Kovacs, M. S., Chronik, B. A., Hudson, R. H. E., Pasternak, S., & Bartha, R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170115 · Cited by 10

Curcumin: The Molecular Mechanisms of Action in Inflammation and Cell Death during Kainate-Induced Epileptogenesis

Yow, H.-Y., Ahmad, N., Azmi, N., & Makmor‐Bakry, M. (2018) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.52.1.4 · Cited by 10

Distinctive alteration in the expression of autophagy genes in Drosophila models of amyloidopathy and tauopathy

Haghi, M., Masoudi, R., & Najibi, S. M. (2020) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2020.1785063 · Cited by 10

Plasticity and the Spread of Alzheimer's Disease-Like Changes

Ohm, T. G., Glöckner, F., Distl, R., Treiber‐Held, S., Meske, V., & Schönheit, B. (2003) · Neurochemical Research · doi:10.1023/a:1026017206925 · Cited by 10

Cathepsin D is specifically inhibited by deoxyribonucleic acids

Shibata, M., Koike, M., Waguri, S., Zhang, G., Koga, T., & Uchiyama, Y. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02569-3 · Cited by 10

A Narrative Review on Breast Cancer Treatment Supported by Focused and Systemic Phytotherapy

Machado, H., Machado, J. P., Alves, C. H. F., Monteiro, M. D. C., Cruz, A., Pinho, C., Soares, C. M. D., Grosso, C., Rodrigues, J. M., & Criado, M. B. (2025) · Nutraceuticals · doi:10.3390/nutraceuticals5040037 · Cited by 9

Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review

Corasaniti, M. T., Bagetta, G., Nicotera, P., Maione, S., Tonin, P., Guida, F., & Scuteri, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021264 · Cited by 10

Overexpression of the IGF-II/M6P Receptor in Mouse Fibroblast Cell Lines Differentially Alters Expression Profiles of Genes Involved in Alzheimer’s Disease-Related Pathology

Wang, Y., Thinakaran, G., & Kar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098057 · Cited by 9

A combinational treatment of carotenoids decreases Aβ secretion in human neurons via β-secretase inhibition

Sho, M., Ichiyanagi, N., Imaizumi, K., Ishikawa, M., Morimoto, S., Watanabe, H., & Okano, H. (2019) · Neuroscience Research · doi:10.1016/j.neures.2019.10.006 · Cited by 9

Strategies to alter the progression of Alzheimer's disease

Siman, R. G. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80070-x · Cited by 9

Correlative cryo-soft X-ray tomography and cryo-structured illumination microscopy reveal changes to lysosomes in amyloid-β-treated neurons

Marshall, K. E., Mengham, K., Spink, M. C., Vania, L., Pollard, H. J., Darrow, M. C., Duke, E., Harkiolaki, M., & Serpell, L. C. (2024) · Structure · doi:10.1016/j.str.2024.02.010 · Cited by 8

Lack of association between cathepsin D C224T polymorphism and Alzheimer’s disease risk: an update meta-analysis

Mo, C., Peng, Q., Sui, J., Wang, J., Deng, Y., Xie, L., Li, T., He, Y., Qin, X. Y., & Li, S. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-13 · Cited by 8

Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer’s Disease Brain

Horta‐López, P. H., Mendoza-Franco, G., Rodríguez‐Cruz, F., Torres-Cruz, F. M., Hernández, E., Jarero-Basulto, J. J., Říčný, J., Florán, B., & García‐Sierra, F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.01.002 · Cited by 7

PHF-Tau from Alzheimer Brain is Rapidly Dephosphorylated and Degraded When Injected into Neurons in situ

Hall, G. F. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-1603 · Cited by 7

Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration

Chai, Y. L., Chong, J. R., Weng, J., Howlett, D., Halsey, A., Lee, J. H., Attems, J., Aarsland, D., Francis, P. T., Chen, C. P., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12631 · Cited by 73

Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease

Nakamura, Y., Takeda, M., Suzuki, H., Hattori, H., Tada, K., Hariguchi, S., Hashimoto, S., & Nishimura, T. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90395-a · Cited by 111

Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease

Cataldo, A., Hamilton, D. J., Barnett, J. L., Paskevich, P. A., & Nixon, R. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00186.1996 · Cited by 356

Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease.

Adamec, E., Mohan, P., Cataldo, A., Srinivasan, A. N., Vonsattel, J., & Nixon, R. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00281-5 · Cited by 116

Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet 6: e1001026

Khurana, V., Elson‐Schwab, I., Fulga, T. A., Sharp, K. A., Loewen, C. A., Mulkearns-Hubert, E. E., Tyynelä, J., Scherzer, C. R., & Feany, M. Β. (2010)